AVTOZMA

NDC 72606-045 · CELLTRION USA, Inc.

Generic nametocilizumab

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)TOCILIZUMAB

Strength162 mg/.9mL

Pharmacologic classInterleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]

Marketing categoryBLA

Packages

72606-045-01 — 1 SYRINGE, GLASS in 1 CARTON (72606-045-01) / .9 mL in 1 SYRINGE, GLASS

72606-045-02 — 4 SYRINGE, GLASS in 1 CARTON (72606-045-02) / .9 mL in 1 SYRINGE, GLASS

72606-045-03 — 12 SYRINGE, GLASS in 1 CARTON (72606-045-03) / .9 mL in 1 SYRINGE, GLASS

72606-045-04 — 1 SYRINGE, GLASS in 1 CARTON (72606-045-04) / .9 mL in 1 SYRINGE, GLASS

72606-045-05 — 4 SYRINGE, GLASS in 1 CARTON (72606-045-05) / .9 mL in 1 SYRINGE, GLASS

72606-045-06 — 12 SYRINGE, GLASS in 1 CARTON (72606-045-06) / .9 mL in 1 SYRINGE, GLASS

Q5156 — Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg Medicare Part B payment limit (ASP + 6%): $4.69

FDA lists these products with the same active ingredient.

50242-136 — tocilizumab, 50242-137 — tocilizumab, 50242-138 — tocilizumab, 50242-143 — tocilizumab, 64406-022 — Tocilizumab, 64406-023 — Tocilizumab, 64406-024 — Tocilizumab, 65219-584 — Tocilizumab-aazg, 65219-586 — Tocilizumab-aazg, 65219-590 — Tocilizumab-aazg, 65219-592 — Tocilizumab-aazg, 65219-594 — Tocilizumab-aazg, 65219-596 — Tocilizumab-aazg, 65219-598 — Tocilizumab-aazg, 72606-042 — tocilizumab, 72606-043 — tocilizumab, 72606-044 — tocilizumab, 78206-200 — TOCILIZUMAB, 78206-201 — TOCILIZUMAB, 78206-202 — TOCILIZUMAB, +1 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.